Novavax (NVAX) shares surge 12% as FDA lifts clinical hold on COVID-19-Influenza Combination vaccine candidates.

(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.

Investing.com -- The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M adjuvant, today ...

Novavax is scheduled to release its third-quarter earnings tomorrow, Tuesday. Data from Benzinga Pro shows a consensus estimate of $(0.83) as adjusted EPS loss and revenues of $65.8 million. Price ...

The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing. The FDA’s decision stems from a report of a serious adverse event of motor ...

People drink takeaway coffee in view of the City of London skyline in London, Britain, July 25, 2024. REUTERS/Hollie Adams/File Photo British public-sector employers now expect to raise pay faster ...

AT&T Inc. Dep. Pfd. (Rep. 1/1000th 4.75% Pfd. Series C) 0.62% ...

Petroleo Brasileiro S/A Ord 1.82% R$479.77B Petroleo Brasileiro S/A Pref 1.89% R$479.77B ...